Form 4: Innovex Insiders Sell 6.6M Shares in Secondary Offering

Multiple entities affiliated with Innovex Co-Invest Fund and Intervale Capital, acting as directors and 10% owners, sold over 6.6 million shares of Innovex International, Inc. common stock in a secondary offering.

Summary

• Innovex Co-Invest Fund, L.P. and several affiliated entities, including Amberjack Capital Fund II, L.P., Innovex Co-Invest Fund II, L.P., Intervale Capital Fund II, L.P., Intervale Capital Fund II-A, L.P., and Intervale Capital Fund III, L.P., collectively disposed of 6,612,500 shares of Innovex International, Inc. common stock.
• The shares were sold on February 27, 2026, as part of an underwritten secondary offering.
• The public offering price for the shares was $25.75 per share.
• The reporting persons received $24.59125 per share, reflecting the public offering price less certain underwriting discounts.
• The transactions were made pursuant to a Rule 10b5-1(c) plan.
• Following the transactions, Amberjack Capital Fund II, L.P. beneficially owns 16,871,374 shares, Innovex Co-Invest Fund II, L.P. owns 3,939,330 shares, Innovex Co-Invest Fund, L.P. owns 933,624 shares, Intervale Capital Fund II, L.P. owns 805,355 shares, Intervale Capital Fund II-A, L.P. owns 399 shares, and Intervale Capital Fund III, L.P. owns 207,240 shares.
• This Form 4 is the second of two filings related to the same event, necessitated by SEC EDGAR system limits on the number of reporting persons per form.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event for the company's operational performance, as it is a secondary offering by existing shareholders, not a primary issuance by the company. The sentiment is slightly tempered by the significant volume of shares sold by insiders, which can sometimes be perceived negatively by the market, though the pre-planned nature mitigates some concern.

Positives

• The sale was executed at a public offering price of $25.75 per share, indicating a strong market valuation for Innovex International, Inc. stock at the time of the offering.
• The transaction was conducted under a Rule 10b5-1(c) plan, suggesting a pre-planned and orderly disposition of shares rather than an immediate reaction to market conditions.

Negatives

• Significant insider selling by multiple large shareholders, including entities identified as directors and 10% owners, could be perceived negatively by the market, potentially signaling a lack of confidence or a desire to diversify holdings away from the company.
• The reporting persons received $24.59125 per share, which is lower than the public offering price of $25.75 due to underwriting discounts, reducing the net proceeds for the sellers.

Risks

• Large-scale insider selling, even if pre-planned, can sometimes put downward pressure on the stock price due to increased supply and potential investor interpretation of insider sentiment.
• The reduction in ownership by these significant shareholders could dilute their influence on corporate governance or strategic direction over time.

Future Outlook

The filing does not contain any explicit forward-looking statements or guidance from the company or reporting persons regarding future performance or strategic direction.

Management Comments

• Jason Turowsky, Partner, signed on behalf of multiple reporting entities, disclaiming beneficial ownership of securities in excess of his pecuniary interests.

Industry Context

StockSavvy.ai notes that secondary offerings by significant shareholders are common events in the lifecycle of publicly traded companies, particularly for private equity funds or early investors looking to realize returns. While not a capital raise for the company itself, such offerings can increase the public float and liquidity of the stock. The discount from the public offering price to the net price received by sellers is standard for underwritten offerings.

Comparison to Industry Standards

• The structure of this secondary offering, including the underwriting discount, aligns with typical industry practices for large block sales of equity securities by institutional investors.
• The use of a Rule 10b5-1 plan is a standard mechanism for insiders to sell shares in a pre-arranged manner, mitigating concerns about trading on material non-public information.

Related Party Transactions

• The transaction involves multiple entities (Amberjack Capital Fund II, L.P., Innovex Co-Invest Fund II, L.P., Innovex Co-Invest Fund, L.P., Intervale Capital Fund II, L.P., Intervale Capital Fund II-A, L.P., and Intervale Capital Fund III, L.P.) that are identified as directors and 10% owners of Innovex International, Inc., making these related party transactions.

Stakeholder Impact

• Shareholders: The increased float from the secondary offering could improve liquidity for Innovex International, Inc. stock. However, the large volume of insider selling might lead to short-term price volatility or negative sentiment.
• Company: The company itself did not raise capital from this transaction, as it was a sale of existing shares by shareholders. The transaction may affect the company's stock price and market perception.

Next Steps

• No specific future actions or milestones are mentioned in this Form 4 filing beyond the completed transaction.

Key Dates

Recommendation

While the significant insider selling might raise questions, the transaction was pre-planned under a Rule 10b5-1 plan, suggesting an orderly disposition rather than an urgent exit. The company's underlying fundamentals are not directly impacted by this secondary offering. Investors should hold and monitor future filings for any changes in company performance or strategic direction, as this filing primarily reflects a liquidity event for large shareholders.

Keywords

Innovex International, INVX, Form 4, Insider Sale, Secondary Offering, Beneficial Ownership, Rule 10b5-1, Equity Securities, Amberjack Capital, Intervale Capital